Regulus Therapeutics

Ticker RGLS

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in San Diego, California

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property…More

Visit website

REPORT RATINGS

4.8 / 5.0 (214)

Regulus Therapeutics reports have an aggregate usefulness score of 4.8 based on 214 reviews.

Regulus Therapeutics

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Regulus Therapeutics does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.